<DOC>
	<DOCNO>NCT00378001</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy general tolerability two different subcutaneous FSH preparation ( Fostimon® , IBSA vs Gonal-F® , Serono Inc. ) administer patient undergo controlled ovarian stimulation IVF .</brief_summary>
	<brief_title>Clinical Efficacy Tolerability Two FSH Preparations ( Human FSH Versus rFSH - Follitropin Alpha ) Women Undergoing IVF</brief_title>
	<detailed_description>This prospective , multicenter , investigator blind , randomize , concurrent control , phase III clinical trial . Patients meet eligibility requirement study randomly assign receive either test drug ( Fostimon® , IBSA ) reference drug ( Gonal-F® , Serono Inc. ) . Investigators blind allow contact study medication ( supply box label manner reveal content box ) , request patient make statement investigator might indicate treatment assign . Equivalence test regard primary outcome variable establish whether two treatment indeed similarly effective .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>&gt; /=18 &lt; 40 year old ; BMI 18 30 kg/m2 ; le 3 previously complete IVF cycle ( i.e . complete cycle = egg recovery ) ; basal FSH &lt; 10 IU/L E2 &lt; 80 pg/mL ; Within 12 month begin study , uterine cavity consistent expect normal function assess hysterosalpingogram , sonohysterogram , hysteroscopic examination ; &gt; 10 antral follicle 210 mm size ; Normal clinically insignificant hematology blood chemistry value . TSH level must within normal limit test laboratory , patient euthyroid determine investigator ( e.g . normal free thyroxine ) . TSH low secondary exogenous thyroid medication patient euthyroid ; Able willing sign Patient Consent Form adhere study visitation schedule . · age &lt; 18 &gt; /=40 year ; primary ovarian failure woman know poor responder ( i.e . require 300 IU FSH start dose previous treatment cycle less 3 oocyte retrieve , E2 serum concentration &lt; 1800 pmol/L/500pg/mL ) ; prior ovarian hyperstimulation syndrome ( OHSS ) , polycystic ovarian syndrome would normally start low FSH dose initially require study ( i.e . 300 IU ) , likely intolerance even two day 300 IU FSH . one ovaries inaccessible oocyte retrieval ; ovarian cyst &gt; 20 mm ; hydrosalpinx surgically remove ligate ; stage 3 4 endometriosis ; oocyte donation ; implantation previously frozen embryo ; patient affect pathology associate contraindication pregnant ; hypersensitivity study medication ; abnormal bleeding undetermined origin ; uncontrolled thyroid adrenal dysfunction ; neoplasia ; severe impairment renal and/or hepatic function ; use concomitant medication might interfere study evaluation ( e.g . nonstudy hormonal medication , prostaglandin inhibitor , psychotropic agent ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Infertility , FSH , IVF , Ovarian stimulation</keyword>
</DOC>